1333121-83-7

Basic information

• Product Name: (3-((4-ethylpiperazin-1-yl)Methyl)phenyl)boronic acid
• Synonyms: (3-((4-ethylpiperazin-1-yl)Methyl)phenyl)boronic acid
• CAS NO: 1333121-83-7
• Molecular Formula: C13H21BN2O2
• Molecular Weight: 248.12904
• Product Categories: Boronate Ester;Boronic Acid;Potassium Trifluoroborate
• Mol File: 1333121-83-7.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 412.3±55.0 °C(Predicted)
• Appearance: /
• Density: 1.14±0.1 g/cm3(Predicted)
• PKA: 8.51±0.10(Predicted)
• CAS DataBase Reference: (3-((4-ethylpiperazin-1-yl)Methyl)phenyl)boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3-((4-ethylpiperazin-1-yl)Methyl)phenyl)boronic acid(1333121-83-7)
• EPA Substance Registry System: (3-((4-ethylpiperazin-1-yl)Methyl)phenyl)boronic acid(1333121-83-7)

Safety Data

• Hazardous Substances Data: 1333121-83-7(Hazardous Substances Data)

Usage

Description

(3-((4-ethylpiperazin-1-yl)Methyl)phenyl)boronic acid, also known as EPMB, is a boronic acid derivative with potential pharmaceutical applications. This chemical compound contains a boronic acid group attached to a phenyl ring, which in turn is attached to a piperazine ring. The boronic acid functional group has been widely studied for its ability to bind to and modulate the activity of biological molecules, particularly enzymes. EPMB's specific structural features make it a potential candidate for use in drug development, particularly in the treatment of diseases such as cancer and diabetes. Additionally, the piperazine ring in EPMB suggests potential use as a central nervous system agent, due to its known pharmacological effects. Further research and development of EPMB may lead to the discovery of novel pharmaceutical products with therapeutic benefits.

Uses

Used in Pharmaceutical Industry:
(3-((4-ethylpiperazin-1-yl)Methyl)phenyl)boronic acid is used as a potential drug candidate for the treatment of diseases such as cancer and diabetes. Its boronic acid functional group allows it to bind to and modulate the activity of biological molecules, particularly enzymes, which can be beneficial in the development of therapeutic agents.
Used in Central Nervous System Agents:
(3-((4-ethylpiperazin-1-yl)Methyl)phenyl)boronic acid is used as a potential central nervous system agent due to the presence of the piperazine ring, which is known for its pharmacological effects. This suggests that EPMB may have potential applications in the development of drugs targeting the central nervous system.